Arch Venture Fund X Overage, 10% Owner of Neumora Therapeutics NMRA, has filed 9 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $5M. The latest trade was on 25/10/27.

AO

AO

Arch Venture Fund X Overage

10% Owner

Company

Neumora Therapeutics NMRA

First filing

23/09/20

Trades

31 trades

Buys / sales

9 / 0

12-month net buying

$5M

Last trade

25/10/27

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Neumora TherapeuticsNMRA	Open-market buy	25/10/27	25/10/29	1,915,700 sh	$2.61	$4,999,977	+46.4%
Prime MedicinePRME	Open-market buy	25/08/01	25/08/01	3,030,300 sh	$3.30	$9,999,990	+94.7%
Boundless BioBOLD	Open-market buy	24/04/02	24/04/04	200,000 sh2 trades	$16.00avg.	$3,200,000	+20.4%
Prime MedicinePRME	Open-market buy	24/02/15	24/02/20	3,200,000 sh	$6.25	$20,000,000	No record
Sana BiotechnologySANA	Open-market buy	24/02/08	24/02/12	1,818,181 sh3 trades	$5.50avg.	$9,999,995.5	+17.1%
Neumora TherapeuticsNMRA	Open-market buy	23/09/19	23/09/20	1,500,000 sh	$17.00	$25,500,000	+70.6%